Replies to post #40066 on Relief Therapeutics Holding AG (RLFTF)

[soliloquy]

Thank you JB I just have one more concern have they let that patent expire? There are a few posting on the yahoo board that that may have happened in 2017? Thanks again

[J-Belfort]

Correction: Well we HAD a patent in India :)

Patent 246915 expired on 07/03/2017

https://ipindiaservices.gov.in/PublicSearch/PublicationSearch/Eregister

I think any actual long investor already assumed India and China would just make their own anyway.

Well at least Aviptidal will help save lives in India. It will moved quickly for approval and get world wide exposure. The rest of the world still is still a market for revenue though. This is still good news IMO. I hope they make enough to give every Indian citizen their own Aviptadil inhaler.

Best,
JB